Skip to main content

Common Alzheimer’s Treatment Linked to Slower Cognitive Decline

This shows a model of a head and a brainCholinesterase inhibitors such as galantamine, donepezil, and rivastigmine, appear to generate persistent cognitive benefits, and increased longevity for up to five years in Alzheimer's patients.

from Neuroscience News https://ift.tt/3lVSWny
Labels:

Comments

Post a Comment

Popular posts from this blog

More Evidence that Patient Portals Improve Patient Care

Of all the medical specialties, neurologists see some of the most complex patients. This idea bears out anecdotally among the neurologists we have interviewed here at Neurology Insights but also statistically. In this 2018 study published in JAMA , neurologists were ranked #3 among physician types for patient complexity as well as for their number of comorbidities (Nephrologists were ranked #1, if you must know). Not surprisingly, among the comorbidities they listed: diabetes . In addition to the neurological sequelae associated with diabetes, this complex and chronic condition often requires well-coordinated care involving repeated testing and care by other providers. A new study published last month (June, 2019) in the journal PlosOne , shows that all this can be improved when these complex patients have access to a patient portal . “A patient portal is a secure online website that gives patients convenient, 24-hour access to personal health information from anywhere with an Inte...
Post a Comment
Read more